학술논문

Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome.
Document Type
Article
Source
Case Reports in Oncology; 2020, Vol. 13 Issue 1, p153-157, 5p
Subject
THROMBOTIC thrombocytopenic purpura
ADULT respiratory distress syndrome
RITUXIMAB
CRITICALLY ill
Language
ISSN
16626575
Abstract
Copyright of Case Reports in Oncology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)